Markers of Proliferative Activity Are Predictors of Patient Outcome for Low-Grade Endometrioid Adenocarcinoma But Not Papillary Serous Carcinoma of Endometrium
- 1 April 2002
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 15 (4) , 365-371
- https://doi.org/10.1038/modpathol.3880531
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- The Ki-67 Protein: Fascinating Forms and an Unknown FunctionExperimental Cell Research, 2000
- The Ki-67 protein: From the known and the unknownJournal of Cellular Physiology, 2000
- MIB-1 in Endometrial Carcinoma: Prognostic Significance with 5-Year Follow-UpGynecologic Oncology, 1999
- p53 expression, p21 expression and the apoptotic index in endometrioid endometrial adenocarcinomaHistopathology, 1999
- Low-Risk Endometrial Carcinoma: Assessment of a Treatment Policy Based on Tumor Ploidy and Identification of Additional Prognostic IndicatorsGynecologic Oncology, 1999
- Cell Proliferation Indexes: a Biomarker in Solid TumorsBiotechnic & Histochemistry, 1997
- p53 overexpression in advanced-stage endometrial adenocarcinomaAmerican Journal of Obstetrics and Gynecology, 1996
- Endometrial CarcinomaNew England Journal of Medicine, 1996
- Proliferation Index Determined by MIB-1 and Recurrence in Endometrial CancerGynecologic Oncology, 1996
- Proliferative and Apoptotic Status in Endometrial AdenocarcinomaInternational Journal of Gynecological Pathology, 1995